MSN Laboratories

Having a wide array of portfolios, MSN Laboratories has 500+ APIs, and its finished dosage form extends to 400+. It works over 35+ therapies, among which oncology, diabetes and cardiology are the segments where the company has a deeper footprint. Outside India, wherefrom it originates, it has a global presence too. The company has 15+ API centers and 8 finished drug houses across the globe in nations like the UAE, Indonesia, and the USA.